Stock Events

Stock Events

Cryo-Cell International 

$3.63
14
+$0.08+2.25% Wednesday 19:54

Statistics

Day High
3.64
Day Low
3.6
52W High
6.51
52W Low
2.72
Volume
1,872
Avg. Volume
16,018
Mkt Cap
29.24M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
May 25
$0.15
Feb 25
$0.25
Nov 24
$0.25
Sep 22
$0.9
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

22AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.46
-0.26
-0.07
0.13
Expected EPS
-0.02
Actual EPS
N/A

Financials

1.26%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
63.97MRevenue
804,000Net Income

Analyst Ratings

$0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CCEL. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vericel
VCEL
Mkt Cap1.77B
Vericel Corporation specializes in cell therapies for patients with serious diseases, overlapping with Cryo-Cell's regenerative medicine services.
Stem
STEM
Mkt Cap164.53M
StemCells, Inc. focuses on developing cell-based therapeutics, sharing the regenerative medicine market with Cryo-Cell.
Mesoblast
MESO
Mkt Cap2.14B
Mesoblast Limited is a leader in developing mesenchymal lineage cell-based therapies, a direct competitor in the regenerative medicine field.
Fate Therapeutics
FATE
Mkt Cap155.7M
Fate Therapeutics is engaged in the development of programmed cellular immunotherapies, competing in the cell therapy market.
Adma Biologics
ADMA
Mkt Cap3.69B
ADMA Biologics, Inc. is involved in the manufacture of human plasma and plasma-derived products, indirectly competing with Cryo-Cell's biobanking services.

About

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Show more...
CEO
Mr. David I. Portnoy
Employees
82
Country
US
ISIN
US2288951088

Listings

F
DE
ZCY.F
XASE
US
CCEL
BOATS
BOATS
CCEL.BOATS

0 Comments

Share your thoughts

FAQ

What is Cryo-Cell International stock price today?▼
The current price of CCEL is $3.63 USD — it has increased by +2.25% in the past 24 hours. Watch Cryo-Cell International stock price performance more closely on the chart.
What is Cryo-Cell International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cryo-Cell International stocks are traded under the ticker CCEL.
Is Cryo-Cell International stock price growing?▼
CCEL stock has risen by +11.69% compared to the previous week, the month change is a +10.67% rise, over the last year Cryo-Cell International has showed a -41.92% decrease.
What is Cryo-Cell International market cap?▼
Today Cryo-Cell International has the market capitalization of 29.24M
When is the next Cryo-Cell International earnings date?▼
Cryo-Cell International is going to release the next earnings report on April 22, 2026.
What were Cryo-Cell International earnings last quarter?▼
CCEL earnings for the last quarter are -0.46 USD per share, whereas the estimation was -0.09 USD resulting in a -411.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cryo-Cell International revenue for the last year?▼
Cryo-Cell International revenue for the last year amounts to 63.97M USD.
What is Cryo-Cell International net income for the last year?▼
CCEL net income for the last year is 804,000 USD.
Does Cryo-Cell International pay dividends?▼
Yes, CCEL dividends are paid quarterly. The last dividend per share was 0.15 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Cryo-Cell International have?▼
As of April 02, 2026, the company has 82 employees.
In which sector is Cryo-Cell International located?▼
Cryo-Cell International operates in the Health Care sector.
When did Cryo-Cell International complete a stock split?▼
Cryo-Cell International has not had any recent stock splits.
Where is Cryo-Cell International headquartered?▼
Cryo-Cell International is headquartered in Oldsmar, US.